Experimental HIV Vaccine Regimen Ineffective in Preventing HIV

The Phase 2b/3 study, named HVTN 702 or Uhambo, began in 2016 and was taking place in South Africa.  The study was canceled because independent data and safety monitoring board (DSMB) found during an interim review that the regimen did not prevent HIV.  The board did not express any concern regarding participant safety.